15.43
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$15.18
Offen:
$15.65
24-Stunden-Volumen:
697.44K
Relative Volume:
1.46
Marktkapitalisierung:
$684.22M
Einnahmen:
$159.01M
Nettoeinkommen (Verlust:
$-21.72M
KGV:
-29.67
EPS:
-0.52
Netto-Cashflow:
$-20.63M
1W Leistung:
-1.41%
1M Leistung:
-12.92%
6M Leistung:
+16.19%
1J Leistung:
+124.93%
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AXGN
Axogen Inc
|
15.43 | 684.22M | 159.01M | -21.72M | -20.63M | -0.52 |
![]()
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-17 | Eingeleitet | Lake Street | Buy |
2024-07-01 | Eingeleitet | Raymond James | Outperform |
2022-11-11 | Fortgesetzt | Jefferies | Buy |
2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2020-10-23 | Eingeleitet | Guggenheim | Buy |
2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
2018-03-02 | Bestätigt | Lake Street | Buy |
2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2017-11-30 | Eingeleitet | Jefferies | Buy |
2017-11-21 | Bestätigt | Lake Street | Buy |
2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
2017-03-06 | Eingeleitet | ROTH Capital | Buy |
2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
2016-11-07 | Bestätigt | Wedbush | Outperform |
2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
2016-08-04 | Bestätigt | Wedbush | Outperform |
2014-05-14 | Eingeleitet | Dawson James | Buy |
2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Axogen and ADMA Biologics expect low to zero impact from recent tariffs - MSN
AxoGen, Inc. (NASDAQ:AXGN) Stock Position Reduced by Geode Capital Management LLC - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Alliancebernstein L.P. - Defense World
JPMorgan Chase & Co. Sells 238,432 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Would Axogen (NASDAQ:AXGN) Be Better Off With Less Debt? - simplywall.st
Analysts Set AxoGen, Inc. (NASDAQ:AXGN) PT at $22.60 - Defense World
American Century Companies Inc. Sells 20,635 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Sei Investments Co. Purchases New Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Financial Comparison: AxoGen (NASDAQ:AXGN) & QT Imaging (NASDAQ:QTI) - Defense World
Corebridge Financial Inc. Has $347,000 Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen Expects Minimal Impact from New Tariffs - TipRanks
Short Interest in AxoGen, Inc. (NASDAQ:AXGN) Declines By 18.4% - Defense World
FY2025 EPS Estimates for AxoGen Boosted by Leerink Partnrs - Defense World
(AXGN) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Shareholders Should Be Pleased With Axogen, Inc.'s (NASDAQ:AXGN) Price - Simply Wall St
PNC Financial Services Group Inc. Decreases Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen: LT Bullish, But Outcomes Weighted To Downside At This Point (NASDAQ:AXGN) - Seeking Alpha
Charles Schwab Investment Management Inc. Has $6.87 Million Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen appoints Rick Ditto as VP, global health economics, reimbursment & policy - TipRanks
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Axogen Announces Appointment of Rick Ditto as Vice - GlobeNewswire
Bank of New York Mellon Corp Trims Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen’s chief innovation officer sells $264,442 in shares - Investing.com India
AxoGen, Inc. (NASDAQ:AXGN) Receives $20.75 Average Target Price from Brokerages - Defense World
US Bancorp DE Makes New $30,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen’s chief innovation officer sells $264,442 in shares By Investing.com - Investing.com UK
Lake Street Initiates Coverage of Axogen (LSE:0HKD) with Buy Recommendation - Nasdaq
AxoGen (NASDAQ:AXGN) Now Covered by Lake Street Capital - Defense World
Lake Street Initiates Coverage of Axogen (AXGN) with Buy Recommendation - Nasdaq
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Lake Street starts AxoGen stock with Buy, sets $30 target By Investing.com - Investing.com Canada
Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 75% - Yahoo
Lake Street starts AxoGen stock with Buy, sets $30 target - Investing.com
Lake Street Initiates Axogen at Buy With $30 Price Target -March 17, 2025 at 08:17 am EDT - Marketscreener.com
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Canada
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth - Investing.com
Cantor maintains AxoGen stock target at $24, bullish on growth plan - Investing.com Australia
Cantor maintains AxoGen stock target at $24, bullish on growth plan By Investing.com - Investing.com South Africa
(AXGN) Technical Data - Stock Traders Daily
Principal Financial Group Inc. Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Cantor Fitzgerald Reaffirms “Overweight” Rating for AxoGen (NASDAQ:AXGN) - Defense World
Rhumbline Advisers Has $960,000 Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen director Amy McBride sells $100,100 in stock By Investing.com - Investing.com Canada
Insider Sell: Amy Wendell Sells 5,000 Shares of Axogen Inc (AXGN) - GuruFocus.com
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):